The effect of RBC transfusions on cytokine gene expression after cardiac surgery in patients developing post-operative multiple organ failure

Transfusion Medicine

Volumn 21, Issue 4, 2011, Pages 236-246

  Sitniakowsky, L S ^a   Later, A F L ^b   van de Watering, L M G ^a   Bogaerts, M ^a   Brand, A ^a,b   Klautz, R J M ^b   Smit, N P M ^b   van Hilten, J A ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac surgery; Cytokines; Gene expression; Multiple organ failure; RBC transfusion

Indexed keywords

ALPHA8 INTERFERON; APROTININ; B CELL ACTIVATING FACTOR; CD135 ANTIGEN; CD40 LIGAND; CORTICOSTEROID; CYTOKINE; FLT3 LIGAND; GROWTH DIFFERENTIATION FACTOR 5; INTERFERON; TRANEXAMIC ACID; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BLEEDING; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOWN REGULATION; ERYTHROCYTE TRANSFUSION; FEMALE; GENE EXPRESSION; GENETIC REGULATION; HEART SURGERY; HUMAN; MALE; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE BLIND PROCEDURE; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UPREGULATION;

AGED; CARDIAC SURGICAL PROCEDURES; CYTOKINES; ERYTHROCYTE TRANSFUSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 79960109518     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2011.01075.x     Document Type: Article

References (35)

1. Abacilar, F., Dogan, O.F., Duman, U., Ucar, I., Demircin, M., Ersoy, U., Dogan, R. & Boke, E. (2006) The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass. The Heart Surgery Forum, 9, E703-E709.
2. Aiboshi, J., Moore, E.E., Ciesla, D.J. & Silliman, C.C. (2001) Blood transfusion and the two-insult model of post-injury multiple organ failure. Shock, 15, 302-306.
3. Ashraf, S., Tian, Y., Cowan, D., Nair, U., Chatrath, R., Saunders, N.R., Watterson, K.G. & Martin, P.G. (1997) "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. The Annals of Thoracic Surgery, 63, 68-73.
4. Asimakopoulos, G., Smith, P.L., Ratnatunga, C.P. & Taylor, K.M. (1999) Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. The Annals of Thoracic Surgery, 68, 1107-1115.
5. Bilgin, Y.M. & Brand, A. (2008) Transfusion-related immunomodulation: a second hit in an inflammatory cascade? Vox Sanguinis, 95, 261-271.
6. Bilgin, Y.M., Van de Watering, L.M., Eijsman, L., Versteegh, M.I., Brand, R., Van Oers, M.H. & Brand, A. (2004) Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation, 109, 2755-2760.
7. Bilgin, Y.M., Van de Watering, L.M., Versteegh, M.I., Van Oers, M.H. & Brand, A. (2010) Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications. Critical Care Medicine, 38, 546-552.
8. Bogner, V., Kirchhoff, C., Baker, H.V., Stegmaier, J.C., Moldawer, L.L., Mutschler, W. & Biberthaler, P. (2007) Gene expression profiles are influenced by ISS, MOF, and clinical outcome in multiple injured patients: a genome-wide comparative analysis. Langenbeck's Archives of Surgery, 392, 255-265.
9. Bossen, C. & Schneider, P. (2006) BAFF, APRIL and their receptors: structure, function and signaling. Seminars in Immunology, 18, 263-275.
10. Damgaard, S., Nielsen, C.H., Andersen, L.W., Bendtzen, K., Tvede, M. & Steinbrüchel, D.A. (2010) Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial. Annals of Thoracic Surgery, 89, 1511-1517.
11. Danese, S. & Fiocchi, C. (2005) Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Critical Reviews in Immunology, 25, 103-121.
12. Diegeler, A., Doll, N., Rauch, T., Haberer, D., Walther, T., Falk, V., Gummert, J., Autschbach, R. & Mohr, F.W. (2000) Humoral immune response during coronary artery bypass grafting: a comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass. Circulation, 102, III95-III100.
13. El Azab, S.R., Rosseel, P.M., De Lange, J.J., Groeneveld, A.B., van Strik, R., Van Wijk E.M. & Scheffer, G.J. (2002) Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. British Journal of Anaesthesia, 88, 496-501.
14. Fu, L., Lin-Lee, Y.C., Pham, L.V., Tamayo, A.T., Yoshimura, L.C. & Ford, R.J. (2009) BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells. Blood, 113, 4627-4636.
15. Greilich, P.E., Brouse, C.F., Whitten, C.W., Chi, L., Dimaio, J.M. & Jessen, M.E. (2003) Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin. The Journal of Thoracic and Cardiovascular Surgery, 126, 1498-1503.
16. Greilich, P.E., Brouse, C.F., Rinder, H.M., Jessen, M.E., Rinder, C.S., Eberhart, R.C., Whitten, C.W. & Smith, B.R. (2008) Monocyte activation in on-pump versus off-pump coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia, 22, 361-368.
17. Holmes, J.H., Connolly, N.C., Paull, D.L., Hill, M.E., Guyton, S.W., Ziegler, S.F. & Hall, R.A. (2002) Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflammation Research, 51, 579-586.
18. John, A.E., Galea, J., Francis, S.E., Holt, C.M. & Finn, A. (1998) Interleukin-8 mRNA expression in circulating leucocytes during cardiopulmonary bypass. Perfusion, 13, 409-417.
19. Khan, S.Y., Kelher, M.R., Heal, J.M. et al. (2006) Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood, 108, 2455-2462.
20. Knaus, W.A., Draper, E.A., Wagner, D.P. & Zimmerman, J.E. (1985) Prognosis in acute organ-system failure. Annals of Surgery, 202, 685-693.
21. Kollef, M.H., Wragge, T. & Pasque, C. (1995) Determinants of mortality and multiorgan dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. Chest, 107, 1395-1401.
22. Later, A.F., Maas, J.J., Engbers, F.H., Versteegh, M.I., Bruggemans, E.F., Dion, R.A. & Klautz, R.J. (2009) Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. European Journal of Cardiothoracic Surgery, 36, 322-329.
23. Later, A.F., Bruggemans, E.F., Romijn, F.P., Van Pelt, J. & Klautz, R.J. (manuscript in preparation) The effects of antifibrinolytics on plasma cytokine levels in cardiac surgery.
24. Mei, Y.Q., Ji, Q., Liu, H. et al. (2007) Study on the relationship of APACHE III and levels of cytokines in patients with systemic inflammatory response syndrome after coronary artery bypass grafting. Biological & Pharmaceutical Bulletin, 30, 410-414.
25. Nannizzi-Alaimo, L., Rubenstein, M.H., Alves, V.L., Leong, G.Y., Phillips, D.R. & Gold, H.K. (2002) Cardiopulmonary bypass induces release of soluble CD40 ligand. Circulation, 105, 2849-2854.
26. Pavlidis, P. & Noble, W.S. (2003) Matrix2png: a utility for visualizing matrix data. Bioinformatics, 19, 295-296.
27. Pitti, R.M., Marsters, S.A., Ruppert, S., Donahue, C.J., Moore, A. & Ashkenazi, A. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. The Journal of Biological Chemistry, 271, 12687-12690.
28. Sablotzki, A., Dehne, M., Welters, I., Menges, T., Lehmann, N., Gorlach, G., Osmer, C. & Hempelmann, G. (1997) Alterations of the cytokine network in patients undergoing cardiopulmonary bypass. Perfusion, 12, 393-403.
29. Sablotzki, A., Dehne, M.G., Mann, V., Gorlach, G., Muhling, J., Zickmann, B. & Hempelmann, G. (1999) Plasma levels of selectins and interleukins in cardiovascular surgery using cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery, 47, 26-31.
30. Sablotzki, A., Friedrich, I., Muhling, J., Dehne, M.G., Spillner, J., Silber, R.E. & Czeslik, E. (2002) The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions. Perfusion, 17, 103-109.
31. Sandoval, S., Alrawi, S., Samee, M., Satheesan, R., Raju, R., Cunningham, J.N. & Acinapura, A.J. A cytokine analysis of the effect of cell saver on blood in coronary bypass surgery. (2001) The heart Surgery Forum, 4, 113-119.
32. Schneider, P., Mackay, F., Steiner, V. et al. (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. The Journal of Experimental Medicine, 189, 1747-1756.
33. Senay, S., Toraman, F., Gunaydin, S., Kilercik, M., Karabulut, H. & Alhan, C. (2009) The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study. Interactive Cardiovascular and Thoracic Surgery, 8, 93-99.
34. Takayama, H., Soltow, L.O. & Aldea G.S. (2007) Differential expression in markers for thrombin, platelet activation, and inflammation in cell saver versus systemic blood in patients undergoing on-pump coronary artery bypass graft surgery. Journal of cardiothoracic and vascular anesthesia, 21, 519-523.
35. Wei, M., Kuukasjarvi, P., Laurikka, J., Pehkonen, E., Kaukinen, S., Laine, S. & Tarkka, M. (2001) Cytokine responses in low-risk coronary artery bypass surgery. The International Journal of Angiology, 10, 27-30.